Advertisement
Advertisement
U.S. markets open in 1 hour 44 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Isracann Biosciences Inc. (IPOT.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
0.0100-0.0050 (-33.33%)
At close: 03:54PM EDT
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.0150
Open0.0000
Bid0.0100 x N/A
Ask0.0150 x N/A
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume82,753
Market Cap1.76M
Beta (5Y Monthly)0.00
PE Ratio (TTM)N/A
EPS (TTM)-0.0300
Earnings DateApr 27, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for IPOT.CN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      Isracann Biosciences Provides Bi-Weekly Default Status Report

      VANCOUVER, British Columbia, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) announces that further to its news release dated September 29, 2022 (the “Default Announcement”), the Company’s principal regulator, the British Columbia Securities Commission (the “BCSC”) granted a management cease trade order (the “MCTO”) on September 29, 2022, under National Policy 12-203 Management Cease Trade Orders (“NP 12-203”). Pursuant to the M

    • GlobeNewswire

      Isracann Biosciences Announces Delay in Filing Annual Financial Statements

      VANCOUVER, British Columbia, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) announces that the filing of its audited annual financial statements for the year ended May 31, 2022, including the related management discussion and analysis, and CEO and CFO certifications (collectively, the “Annual Financial Filings”) were not filed by the required filing deadline of September 28, 2022 (the “Filing Deadline”). The Annual Financial F

    • GlobeNewswire

      Isracann Bioscience Facilitated Genetics Arrive in Israel

      Partner Facility Now Growing Canadian Cannabis StrainsVANCOUVER, British Columbia, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor is pleased to announce that previously shipped genetics have cleared Israeli customs and are being raised as mother stock. “The Israeli market will now have access to premium Canad

    Advertisement
    Advertisement